Cargando…
Correction: Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
Autores principales: | Wang, Jinkui, Li, Mujie, Guo, Peng, He, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626720/ https://www.ncbi.nlm.nih.gov/pubmed/37926811 http://dx.doi.org/10.1186/s13018-023-04326-y |
Ejemplares similares
-
Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
por: Wang, Jinkui, et al.
Publicado: (2023) -
A Nomogram for Predicting Cancer-Specific Survival of Osteosarcoma and Ewing's Sarcoma in Children: A SEER Database Analysis
por: Wang, Jinkui, et al.
Publicado: (2022) -
Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo
por: Wang, Jinkui, et al.
Publicado: (2022) -
Author Correction: Prognostic nomogram for predicting 5-year overall survival in Chinese patients with high-grade osteosarcoma
por: Yao, Zhihong, et al.
Publicado: (2021) -
Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis
por: Wang, Jinkui, et al.
Publicado: (2022)